Novel Combination Therapy for Triple-Negative Breast Cancer based on an Intelligent Hollow Carbon Sphere

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with high mortality, and the efficacy of monotherapy for TNBC is still disappointing. Here, we developed a novel combination therapy for TNBC based on a multifunctional nanohollow carbon sphere. This intelligent material contains a superadsorbed silicon dioxide sphere, sufficient loading space, a nanoscale hole on its surface, a robust shell, and an outer bilayer, and it could load both programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) small-molecule immune checkpoints and small-molecule photosensitizers with excellent loading contents, protect these small molecules during the systemic circulation, and achieve accumulation of them in tumor sites after systemic administration followed by the application of laser irradiation, thereby realizing dual attack of photodynamic therapy and immunotherapy on tumors. Importantly, we integrated the fasting-mimicking diet condition that can further enhance the cellular uptake efficiency of nanoparticles in tumor cells and amplify the immune responses, further enhancing the therapeutic effect. Thus, a novel combination therapy “PD-1/PD-L1 immune checkpoint blockade + photodynamic therapy + fasting-mimicking diet”was developed with the aid of our materials, which eventually achieved a marked therapeutic effect in 4T1-tumor-bearing mice. The concept can also be applied to the clinical treatment of human TNBC with guiding significance in the future.

[1]  L. Carey,et al.  Triple negative breast cancer: Pitfalls and progress , 2022, NPJ breast cancer.

[2]  Lakshmi Kalyani Ruddaraju,et al.  A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents , 2022, BioNanoScience.

[3]  V. Torri,et al.  Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer , 2021, Cancer discovery.

[4]  Zihai Li,et al.  Combination strategies to maximize the benefits of cancer immunotherapy , 2021, Journal of Hematology & Oncology.

[5]  D. Bokov,et al.  Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol , 2021, Frontiers in Bioengineering and Biotechnology.

[6]  M. Hooning,et al.  Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm? , 2021, Cancers.

[7]  M. Soukhtanloo,et al.  A review on liposome-based therapeutic approaches against malignant melanoma. , 2021, International journal of pharmaceutics.

[8]  Yili Yang,et al.  A metal-free nanozyme-activated prodrug strategy for targeted tumor catalytic therapy , 2020 .

[9]  Christopher B. Howard,et al.  Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting. , 2020, ACS nano.

[10]  Sa Xiao,et al.  Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma. , 2020, International journal of pharmaceutics.

[11]  W. Lee,et al.  Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity , 2020, Experimental & Molecular Medicine.

[12]  L. Rivoltini,et al.  Fasting-mimicking diet plus chemotherapy in breast cancer treatment , 2020, Nature Communications.

[13]  Jin Wang,et al.  Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction As Potential Anticancer Agents. , 2020, Journal of medicinal chemistry.

[14]  Dongsen Mao,et al.  Nitrogen-doped hollow carbon spheres with tunable shell thickness for high-performance supercapacitors , 2020, RSC advances.

[15]  Cristina Martín,et al.  Degradation of Structurally Defined Graphene Nanoribbons by Myeloperoxidase and Photo-Fenton Reaction. , 2020, Angewandte Chemie.

[16]  G. Curigliano,et al.  Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers , 2020, Nature Communications.

[17]  R. Zhang,et al.  Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer. , 2019, Small.

[18]  Xiaojie Li,et al.  Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles , 2019, International journal of nanomedicine.

[19]  M. I. Setyawati,et al.  Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness , 2019, Nature Nanotechnology.

[20]  T. Minko,et al.  Metastatic and triple-negative breast cancer: challenges and treatment options , 2018, Drug Delivery and Translational Research.

[21]  A. Serajuddin,et al.  Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self‐emulsifying lipid‐based formulations , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  L. Skalniak,et al.  Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells , 2017, Oncotarget.

[23]  E. Tasciotti,et al.  Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy. , 2017, ACS applied materials & interfaces.

[24]  Herman Yeger,et al.  Combination therapy in combating cancer , 2017, Oncotarget.

[25]  M. Alsharedi,et al.  Immunotherapy in triple-negative breast cancer , 2017, Medical Oncology.

[26]  R. Weichselbaum,et al.  Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. , 2016, Journal of the American Chemical Society.

[27]  A. Star,et al.  Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications. , 2016, Toxicology and applied pharmacology.

[28]  Gang Bao,et al.  The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. , 2016, Nanomedicine.

[29]  Fan Wang,et al.  Enhanced Anti-Tumor Efficacy through a Combination of Integrin αvβ6-Targeted Photodynamic Therapy and Immune Checkpoint Inhibition , 2016, Theranostics.

[30]  A. Elzatahry,et al.  Design, synthesis and applications of core-shell, hollow core, and nanorattle multifunctional nanostructures. , 2016, Nanoscale.

[31]  H. Babaei,et al.  Effect of pore size and shape on the thermal conductivity of metal-organic frameworks , 2016 .

[32]  Upendra Nagaich,et al.  Mesoporous silica nanoparticles in target drug delivery system: A review , 2015, International journal of pharmaceutical investigation.

[33]  K. Kinzler,et al.  Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells , 2014, Journal of Immunotherapy for Cancer.

[34]  Yong Zhao,et al.  Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo. , 2013, Advanced drug delivery reviews.

[35]  Xue-guang Zhang,et al.  Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice. , 2013, Cancer letters.

[36]  K. Ewert,et al.  Materials chemistry: Liposomes derived from molecular vases , 2012, Nature.

[37]  Fang Zeng,et al.  Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles , 2011, Nanotechnology.

[38]  Hyunjoon Song,et al.  Metal@Silica yolk-shell nanostructures as versatile bifunctional nanocatalysts , 2011 .

[39]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[40]  G. Lu,et al.  Magnetic nanocomposites with mesoporous structures: synthesis and applications. , 2011, Small.

[41]  Judith Klein-Seetharaman,et al.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.

[42]  Kinam Park,et al.  Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction , 2010, Expert opinion on drug delivery.

[43]  H. Choi,et al.  In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. , 2009, ACS Nano.

[44]  M. Grisham Reactive oxygen species in immune responses. , 2004, Free radical biology & medicine.